Association between Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma: A Korean Nationally Representative Cohort Study

Association between Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma: A Korean Nationally Representative Cohort Study

(1) Background: The association between proton pump inhibitor (PPI) use and hepatocellular carcinoma (HCC) has been controversial, especially in the general population. We aimed to determine the impact of PPI on HCC risk in participants without liver cirrhosis or chronic hepatitis virus infection. (...

Full description

Bibliographic Details
Main Authors:	Soungmun Kim, Seogsong Jeong, Sun Jae Park, Jooyoung Chang, Seulggie Choi, Yoosun Cho, Joseph C. Ahn, Gyeongsil Lee, Joung Sik Son, Sang Min Park
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Series:	Journal of Clinical Medicine
Subjects:	epidemiology pharmacoepidemiology proton pump inhibitor hepatocellular carcinoma liver cirrhosis chronic liver diseases
Online Access:	https://www.mdpi.com/2077-0383/11/10/2865

Similar Items

Effects of proton pump inhibitor on gastroesophageal varices in patients with cirrhosis: A randomized controlled trial from China
by: Xiaoning Chen, et al.
Published: (2023-03-01)

PROTON PUMP INHIBITORS INCREASE THE OVERALL RISK OF DEVELOPING BACTERIAL INFECTIONS IN PATIENTS WITH CIRRHOSIS
by: Illce B LÁZARO-PACHECO, et al.

Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver
by: Heloisa B. Assalin, et al.
Published: (2022-11-01)

Kidney function decline associated with proton pump inhibitors: results from the ELSA-Brasil cohort
by: Andrêza Soares dos Santos, et al.
Published: (2023-09-01)

Proton Pump Inhibitor Therapy Does Not Affect Prognosis of Cirrhosis Patients With Acute Decompensation and Acute-on-Chronic Liver Failure: A Single-Center Prospective Study
by: Shanshan Sun, et al.
Published: (2021-11-01)

The Dark Side of the Long-Term Use of Proton Pump Inhibitors in Chronic Liver Disease
by: Samuel Raimundo Fernandes, et al.
Published: (2018-05-01)

Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019-08-01)

Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019-08-01)

Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients
by: Chien-Huei Huang, et al.
Published: (2024-01-01)

Proton pump inhibitor treatment aggravates bacterial translocation in patients with advanced cirrhosis and portal hypertension
by: Lukas Sturm, et al.
Published: (2023-10-01)

A dual role of proton pump inhibition on cancer: a critical review
by: Edizer Deniz Tuna, et al.
Published: (2023-02-01)

Electroencephalography Signatures for Hepatic Encephalopathy in Cirrhosis Patients Treated with Proton Pump Inhibitors: An Exploratory Pilot Study
by: Pan Zhang, et al.
Published: (2022-11-01)

Effects of the Long-term Treatment of Proton Pump Inhibitors on the Function of Kidney and Liver in Laboratory Female Rats
by: S. M. J AL-Hadrawy, et al.
Published: (2021-10-01)

A Novel Machine Learning-Based Point-Score Model as a Non-Invasive Decision-Making Tool for Identifying Infected Ascites in Patients with Hydropic Decompensated Liver Cirrhosis: A Retrospective Multicentre Study
by: Silvia Würstle, et al.
Published: (2022-11-01)

Adverse Effects of Proton Pump Inhibitors—Evidence and Plausibility
by: Reidar Fossmark, et al.
Published: (2019-10-01)

Proton pump inhibitors overuse: only inappropriate prescriptions or further iatrogenic damage?
by: Mario Visconti
Published: (2015-09-01)

Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease
by: Byungkyu Ahn, et al.
Published: (2016-07-01)

Proton Pump Inhibitors and Gastric Cancer
by: Seungkyung Kang, et al.
Published: (2021-09-01)

Syndrome of inappropriate antidiuretic hormone secretion is associated with different proton pump inhibitor use: a pharmacovigilance study
by: Mengmeng Wang, et al.
Published: (2022-05-01)

Use of Proton Pump Inhibitors in Hungary: Mixed-Method Study to Reveal Scale and Characteristics
by: Mária Matuz, et al.
Published: (2020-09-01)

Proton pump inhibitors- Adversaries in our fight against antibiotic resistance?
by: Sumayya Umar, et al.
Published: (2023-10-01)

Correlation between Myosteatosis and Liver Fibrosis among Patients with Non Alcoholic Fatty Liver Disease: A Cross-Sectional Study
by: Samhita Ankala, et al.
Published: (2023-11-01)

Proton Pump Inhibitors: Are we prescribing them right?
by: Eduardo Esteban-Zubero
Published: (2021-10-01)

Incidence of hypomagnesemia on proton pump inhibitors at the Huntington Veterans Affairs Medical Center – IHOP
by: Ebrahim Sabbagh, et al.
Published: (2016-07-01)

Influence of proton pump inhibitor therapy on intestinal inflammation assessed by fecal calprotectin in pediatric patients
by: Su Yeong Kim, et al.
Published: (2019-10-01)

Effects of Proton Pump Inhibitors on Patient Survival in Patients Undergoing Maintenance Hemodialysis
by: Seok Hui Kang, et al.
Published: (2023-07-01)

Optimal Use of Proton Pump Inhibitors and Potassium-competitive Acid Blockers
by: Jong Kyu Park
Published: (2023-09-01)

Proton pump inhibitors use and risk of developing spontaneous bacterial peritonitis in cirrhotic patients: A systematic review and meta-analysis
by: Saad Alhumaid, et al.
Published: (2021-03-01)

Association Between Low Muscle Mass and Non-alcoholic Fatty Liver Disease Diagnosed Using Ultrasonography, Magnetic Resonance Imaging Derived Proton Density Fat Fraction, and Comprehensive NAFLD Score in Korea
by: Hun Ju Lee, et al.
Published: (2021-11-01)

Proton pump inhibitors and dementia: what association?
by: Catarina Caetano, et al.
Published: (2023-05-01)

Proton pump inhibitors usage and the risk of cancer
by: Hubert Wróblewski, et al.
Published: (2021-08-01)

Proton Pump Inhibitors: Are They a Real Threat to the Patient?
by: Sofia Xavier, et al.
Published: (2018-02-01)

Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study
by: Kanokwan Pinyopornpanish, et al.
Published: (2021-10-01)

Association between Proton Pump Inhibitor Use and Parkinson’s Disease in a Korean Population
by: Ji-Hee Kim, et al.
Published: (2022-03-01)

Is It More Effective to Prescribe a Proton Pump Inhibitor Separately before a Meal for the Eradication of Helicobacter pylori?
by: Gyu Won Lee, et al.
Published: (2018-06-01)

Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults
by: Seogsong Jeong, et al.
Published: (2022-07-01)

Changes in serum magnesium concentration after use of a proton pump inhibitor in patients undergoing percutaneous coronary intervention
by: Sang-Ho Park, et al.
Published: (2015-06-01)

Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study
by: Paul M. McKeigue, et al.
Published: (2021-02-01)

Proton pump inhibitors induce hemolytic anemia
by: Asayil Nasser Al-Nasser, et al.
Published: (2019-01-01)

Safety and Potential Risks of Prolonged Use of Proton Pump Inhibitors
by: S.M. Tkach
Published: (2014-02-01)